Literature DB >> 11317366

Identification of four novel polymorphisms in the calcitonin/alpha-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression.

S Buervenich1, F Xiang, O Sydow, E G Jönsson, G C Sedvall, M Anvret, L Olson.   

Abstract

We identified novel polymorphisms in the calcitonin/CGRPalpha (CALCA) gene by direct sequencing of genomic DNA and subsequent genotyping by RFLP (restriction fragment length polymorphism) detection and investigated association with neurological or psychiatric disease. Four novel polymorphic alleles were found: two (g.979G>A and g.4218T>C) represented single nucleotide polymorphisms (SNPs), one consisted of two coupled SNPs in close vicinity to each other (g.1210T>C and g.1214C>G), and one was an intronic 16-bp microdeletion (2919-2934del16). One of the SNPs (g.4218T>C) causes a non-synonymous amino acid change (Leu66Pro) in the third exon, an exon common to both procalcitonin and pro-alpha-CGRP. In a subsequent association study, frequencies of the identified polymorphisms in Parkinson and schizophrenia patients were compared with frequencies in the normal population. No statistically significant association was found in our material. The 16-bp microdeletion polymorphism was present in a family with multiple cases of unipolar or bipolar depressive disorder. Using this polymorphism as marker, cosegregation with the phenotype was observed in the majority of individuals. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11317366     DOI: 10.1002/humu.1126

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  CGRP 4218T/C polymorphism correlated with postoperative analgesic effect of fentanyl.

Authors:  Yusheng Yi; Mingqiang Zhao; Fenghe Xu; Chuansheng Liu; Yanwei Yin; Junmin Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  The association of single nucleotide polymorphisms in the calcitonin gene with primary osteoarthritis of the knee in Mexican mestizo population.

Authors:  J J Magaña; B Muñoz; V M Borgonio-Cuadra; C Razo-Estrada; C González-Huerta; S Cortés-González; A Albores; A Miranda-Duarte
Journal:  Rheumatol Int       Date:  2013-04-11       Impact factor: 2.631

3.  Tnfrsf12a-Mediated Atherosclerosis Signaling and Inflammatory Response as a Common Protection Mechanism of Shuxuening Injection Against Both Myocardial and Cerebral Ischemia-Reperfusion Injuries.

Authors:  Ming Lyu; Ying Cui; Tiechan Zhao; Zhaochen Ning; Jie Ren; Xingpiao Jin; Guanwei Fan; Yan Zhu
Journal:  Front Pharmacol       Date:  2018-04-06       Impact factor: 5.810

Review 4.  CGRP: A New Endogenous Cell Stemness Maintenance Molecule.

Authors:  Xiaoting Lv; Qingquan Chen; Shuyu Zhang; Feng Gao; Qicai Liu
Journal:  Oxid Med Cell Longev       Date:  2022-01-29       Impact factor: 6.543

5.  Association between AKT1 gene and Parkinson's disease: a protective haplotype.

Authors:  Georgia Xiromerisiou; Georgios M Hadjigeorgiou; Alexandros Papadimitriou; Evaggelos Katsarogiannis; Vasiliki Gourbali; Andrew B Singleton
Journal:  Neurosci Lett       Date:  2008-03-15       Impact factor: 3.046

6.  BCL2-938C>A and CALCA-1786T>C polymorphisms in aseptic loosened total hip arthroplasty.

Authors:  Christian Wedemeyer; M D Kauther; S Hanenkamp; H Nückel; M Bau; W Siffert; H S Bachmann
Journal:  Eur J Med Res       Date:  2009-06-18       Impact factor: 2.175

7.  No Association of CALCA Polymorphisms and Aseptic Loosening after Primary Total Hip Arthroplasty.

Authors:  Tünay Aydin-Yüce; Gina Kurscheid; Hagen Sjard Bachmann; Thorsten Gehrke; Marcel Dudda; Markus Jäger; Christian Wedemeyer; Max Daniel Kauther
Journal:  Biomed Res Int       Date:  2018-06-05       Impact factor: 3.411

8.  Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion.

Authors:  Lars Edvinsson; Anne-Sofie Grell; Karin Warfvinge
Journal:  J Mol Neurosci       Date:  2020-02-22       Impact factor: 3.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.